News – Page 1191 – Endpoints News

Kite grabs a stem cell biology ‘breakthrough’ in race for off-the-shelf T cell therapies

9 years ago

Protocols: Tricida bags $55M round for CKD drug; $MRK gets a 'breakthrough’;

9 years ago

PTC faces a delay in Europe for controversial Duchenne drug

9 years ago

Eyeing an IPO, Alzheon looks to raise $100M for a “derisked” Alzheimer’s PhIII

9 years ago

Tobira crushed after NASH drug flunks a PhIIb, but slice of data drives PhIII plans

9 years ago

FDA lifts a hold on a Novartis hearing loss drug, and tiny GenVec gets a lift

9 years ago

AbbVie hustles its unicorn drug Rova-T into the clinic in combo with Bristol's Opdivo

9 years ago

Shire bags a quick thumbs up for its newly won cancer drug pipeline

9 years ago

Are 'great' tweeters born? Or can they be made? A conversation with Adam Feuerstein.

9 years ago

Top stories of the week: Thumbs up/Thumbs down

9 years ago

Pfizer/Spark team gets a ‘breakthrough’ in gene therapy alliance

9 years ago

Funded for PhII, biotech entrepreneurs achieve a 15-year-old R&D dream

9 years ago

Exhibit A in Valeant’s blockbuster R&D boast runs into trouble at the FDA

9 years ago

What’s the hottest biotech R&D field in venture investing?

9 years ago

Rhythm eyes a pivotal test after rolling through PhII with upbeat results for rare obesity cases

9 years ago

With biosimilars gaining momentum, Amgen and Allergan cite success of Herceptin's copycat

9 years ago

The Scangos legacy: A blockbuster MS record with lingering doubts about the pipeline

9 years ago

Sidelined at the FDA, AstraZeneca watches as new team seizes rival drug in $1.5B Relypsa buyout

9 years ago

New CEO Szela cuts Aegerion staff again, pulls Juxtapid out of the EU

9 years ago

BioRegnum: Another great reason emerges for AstraZeneca to target new biotech deals

9 years ago

Merck is scouting sites for a new research hub in the Bay Area, plans new hires

9 years ago

AstraZeneca culls its neuroscience team, exits Kendall Square office

9 years ago

By the numbers: 2-year tally of Celgene's biotech partnership deals tops $3B in cash

9 years ago

AveXis wins the inside track at the FDA with gene therapy ‘breakthrough’

9 years ago

First page Previous page 1188 1189 119011911192 1193 1194 Next page Last page